Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Non Operating Income (2020 - 2025)

Historic Non Operating Income for IDEAYA Biosciences (IDYA) over the last 6 years, with Q4 2025 value amounting to $11.3 million.

  • IDEAYA Biosciences' Non Operating Income fell 1829.16% to $11.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $51.0 million, marking a year-over-year decrease of 287.82%. This contributed to the annual value of $45.6 million for FY2025, which is 1311.1% down from last year.
  • As of Q4 2025, IDEAYA Biosciences' Non Operating Income stood at $11.3 million, which was down 1829.16% from $10.8 million recorded in Q3 2025.
  • Over the past 5 years, IDEAYA Biosciences' Non Operating Income peaked at $15.1 million during Q3 2024, and registered a low of $104000.0 during Q2 2021.
  • Its 5-year average for Non Operating Income is $5.6 million, with a median of $3.7 million in 2023.
  • In the last 5 years, IDEAYA Biosciences' Non Operating Income soared by 132802.55% in 2022 and then tumbled by 2839.7% in 2025.
  • IDEAYA Biosciences' Non Operating Income (Quarter) stood at $157000.0 in 2021, then skyrocketed by 1328.03% to $2.2 million in 2022, then soared by 255.13% to $8.0 million in 2023, then surged by 73.65% to $13.8 million in 2024, then dropped by 18.29% to $11.3 million in 2025.
  • Its Non Operating Income was $11.3 million in Q4 2025, compared to $10.8 million in Q3 2025 and $13.8 million in Q4 2024.